Inventiva (NASDAQ:IVA – Get Free Report) will be issuing its 06/30/2023 quarterly earnings data after the market closes on Thursday, September 28th. Analysts expect the company to announce earnings of ($0.88) per share for the quarter.
Inventiva Price Performance
Shares of IVA opened at $4.31 on Tuesday. The firm’s 50 day simple moving average is $3.81 and its 200 day simple moving average is $3.64. The company has a quick ratio of 3.45, a current ratio of 3.47 and a debt-to-equity ratio of 0.63. Inventiva has a 1-year low of $2.22 and a 1-year high of $11.75.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Citigroup Inc. grew its holdings in shares of Inventiva by 91.7% in the first quarter. Citigroup Inc. now owns 23,000 shares of the company’s stock worth $84,000 after purchasing an additional 11,000 shares during the last quarter. Commonwealth Equity Services LLC bought a new position in shares of Inventiva in the first quarter worth approximately $51,000. Finally, Morgan Stanley grew its holdings in shares of Inventiva by 300.0% in the fourth quarter. Morgan Stanley now owns 6,000 shares of the company’s stock worth $27,000 after purchasing an additional 4,500 shares during the last quarter. 11.46% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Get Our Latest Report on Inventiva
Inventiva Company Profile
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease.
Featured Stories
- Five stocks we like better than Inventiva
- Following Congress Stock Trades
- 2 Must-Have Silicon Companies That Don’t Make Microchips
- Earnings Per Share Calculator: How to Calculate EPS
- Small Caps That Have Priced In A Hard Landing For Big Upside
- Financial Services Stocks Investing
- This May Have Ended Alibaba’s Winter, But Is It Time To Buy?
Receive News & Ratings for Inventiva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inventiva and related companies with MarketBeat.com's FREE daily email newsletter.
